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For the last 10 years and after important discoveries such as DNA sequence 
of the entire human genome, there has been a considerable increase in the 
interest on researches risk prediction models associated with genetic originated 
diseases through two principal approaches: Polygenic Risk Score and Machine 
Learning techniques. The aim of this work is the literature review on Machine 
Learning techniques applied to obtaining the polygenic risk score, highlighting 
the most relevant researches and applications at present. The application 
of these techniques has provided many benefits in the prediction of diseases 
mot it is evident that the challenges of the use and optimization of these two 
approaches are still being discussed and investigated in order to have a greater 
precision in the prediction of genetic diseases.
1. Introduction
Advances in medicine and technology have enabled researchers to gather a wide range of infor-
mation on the prediction of genetic diseases at a rapid rate. Complex human diseases such as cancer, 
cardiovascular, respiratory diseases and neurological disorders have caused enormous public health 
problems and economic loads (Ferlay et al., 2013). Environmental factors such as smoking exposure, 
nutrient intake, physical exercise and genomic factors are believed to contribute to the development of 
complex human diseases (World Health Organization, 2018).
The aim of the work was to investigate the applicability of Machine Learning (ML) techniques 
and the Polygenic Risk Score (PRS) for prediction genetic diseases. In order to achieve the objec-
tive searches were conducted to identify relevant literature using the terms “machine learning and 
6
Nibeth Mena Mamani 
Machine Learning techniques and Polygenic Risk 
Score application to prediction genetic diseases
ADCAIJ: Advances in Distributed Computing 
and Artificial Intelligence Journal 
Regular Issue, Vol. 9 N. 1 (2020), 5-14
eISSN: 2255-2863 - https://adcaij.usal.es
Ediciones Universidad de Salamanca - cc by-nc-nd
polygenic risk score”. First, a literature search was conducted through health and technology related 
research databases like PubMed and Science Direct. The Figure 1 is reflecting the considerable growth 
of articles published that contain the terms “machine learning and polygenic risk score” in the last 10 
year ago.
Study selection was on base of the publication range for articles from 2015 to 2019 where the 
articles were included in the review if the following criteria were met: 1) The article had both terms 
“machine learning and polygenic risk score” in the title, abstract or content. 2) The article reported of 
ML techniques to address prediction genetic diseases and 3) The article was available in English. The 
articles were excluded if the following criteria were met: 1) The article report ML techniques but not 
focused to prediction genetic diseases using PRS and 2) The full text of the article was not available.
The search strategies identified 630 articles, with 50 of these articles meeting the inclusion criteria 
and 580 articles excluded for not met the inclusion criteria. From 50 articles reviewed with inclusion 
criteria applied 29 articles were excluded for met the exclusion criteria and finally there are 21 articles 
included in the literature review.
Figure 1: Articles published with “machine learning and polygenic risk score” in the title or content 
2. Background
The great advances in technology have allowed scientists to make significant discoveries. A robust 
technique that has emerged to analyze this data is machine learning (ML), which aims to construct 
systems that can automatically improve through experience using advanced statistical and probabilistic 
techniques (Jordan et al., 2015). ML has provided significant benefits to a range of fields including 
artificial intelligence, computer vision, speech recognition and natural language processing allowing 
researchers and developers to extract vital information from data, provide personalized experiences 
and develop intelligent systems (Jordan et al., 2015). Within the field of medicine, the ML has brought 
significant advances allowing predictions of genetic diseases with complex data and variables (Ho et 
al., 2019).
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Nowadays, most of the diseases originate from genetic mutations in the DNA. In order to pre-
dict a disease, there are two main approaches. The first is the polygenic risk score known as a tradi-
tional approach which is a probabilistic data obtained through statistical techniques that predict the 
probability of contracting any genetic disease. The second approach is Machine Learning techniques 
which through a set of supervised and unsupervised algorithms predict the probability of contracting 
the genetic disease. Both approaches continue to be studied after the appearance of dependencies or 
factors that are external to genetics such as the environment, healthy habits, etc. which influence the 
development of the disease. Each study has a particular case where either PRS or ML are applied to 
predict a particular disease; There are studies where both approaches where applied to finally make the 
comparison of precision in the prediction. The objective of these approaches is to achieve maximum 
precision in the prediction of polygenic disorders. However, both approaches have challenges and 
limitations that are currently being investigated by scientists and doctors.
2.1. Genome-Wide Association Studies – GWAS
Thanks to the Next Generation Sequencing (NGS), which allows sequencing of the entire ge-
nome, a big leap from gene association study to Genome-wide Association Study known as GWAS 
was made. GWAS are studies that examine all the existing mutations in the genome by increasing the 
probability of finding the gene or genes that cause a certain disease. There are millions of single nucle-
otide polymorphisms (SNPs, also known as genetic variants). GWA identify SNPs that mark genomic 
regions that are strongly associated with phenotypes in a population. These genomic regions must 
contain the variant that is causally associated with the phenotype. However, it does not follow that the 
SNP identified by the GWA study is causal. In particular many common and complex diseases (e.g., 
type 2 diabetes (T2D) and obesity) are influenced by multiple SNPs each with small SNP effect sizes. 
GWA studies define SNPs according to their association with a disease / phenotype at the population 
level (Ho et al., 2019).
3. Polygenic Risk Score – PRS
The polygenic risk score uses a fixed model approach to add the contribution of a set of risk alleles 
to a specific complex disease (Amin et al., 2009).
 In 2007 a method was proposed for examining the aggregate influence of multiple genetic markers 
by Wray et al. (2007). The method involved generating a PRS based on the results of a GWAS. After 
running a GWAS on a discovery sample, SNPs are selected for inclusion in the PRS based on their 
association with the phenotype. Using a validation sample, the PRS can be calculated as a sum of the 
alleles associated with the phenotype (often weighted by the specific SNP coefficients of the GWAS). 
With that score the joint association of multiple SNPs with the given trait can be evaluated. In general 
the PRS techniques have become increasingly popular facilitating genetic discoveries for complex 
traits. However since they are based on linear combinations of markers, traditional PRSs may not cap-
ture nonlinearity among SNPs (Levie et al., 2017).
The best known and used software for estimating PRS in studies on the prediction of risk of genetic 
diseases is PRSice (https://www.prsice.info). That software allows to calculate of the PRS, evaluate 
and analyze the results of the PRSs (Choi et al., 2019; Euesden et al., 2019).
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4. Machine Learning Techniques
Machine learning approaches adapt a set of sophisticated statistical and computational algorithms. 
The application of these techniques based on their set of supervised and unsupervised algorithms 
offers several application approaches such as profile analysis, disease diagnosis, drug development 
(Kristy et al., 2018; Vamathevan et al., 2019), disease prediction, detect epistasis within the human 
genome (McKinney et al., 2006). These techniques: support vector machine (SVM) (Cortes et al., 
1995), Random forests (Breiman et al., 2001) and k-nearest neighbors (Altman et al., 1992), have been 
successfully applied in the prediction of risk of complex diseases according to clinical data (Zhang et 
al., 2016; Gao et al., 2018; Wu et al., 2018; Antonucci et al., 2019).
In Gao’s study (Gao et al., 2018) of prediction and classification of Parkinson disease, for example, 
several methods are used without models like Random Forest, AdaBoost, XGBoost, Support Vector 
Machines, Neural Network and SuperLearner. Like the development of the PRS, the ML algorithms 
have the development and validation phase. In the development phase the algorithm will be trained 
with a dataset selected, in the validation phase as well as the PRS evaluates the prediction power in an 
independent dataset, adding a final validation called Test using another independent dataset so that the 
prediction power is finally confirmed (Ho et al., 2019). 
These algorithms benefit from constant learning or retraining, since they do not guarantee opti-
mized classification / regression results. However, when properly and effectively trained, maintained 
and reinforced, automatic learning methods without models have great potential for solving real-world 
problems (prediction and data mining) (Gao et al., 2018). 
Machine learning covers an extensive class of algorithms widely used to solve complex prediction 
problems. Regression trees are ideal for updating SNP weights in polygenic risk scores. This gradi-
ent-powered technique is powerful and versatile methods for continuous prediction of results. Gradient 
Boosting (Shapire et al., 2012) is an efficient algorithm that sequentially combines a large number of 
weakly predictive models to optimize performance (Paré et al., 2017).
4.1. Deep Learning
Deep learning algorithms developed from neural network algorithms have gained much interest af-
ter their successful implementation in image recognition and natural language processing applications. 
In genomics, deep learning applications are helping to identify functional DNA sequences, protein 
binding motifs, epigenetic markers (Ho et al., 2019), model the complex dependencies of the genome 
to provide predictors (Telenti et al., 2018), also has been used for discovery of sites for regulation 
or splicing (Leung et al., 2014; Xiong et al., 2015 ) and prediction of variant functions (Zhou et al., 
2015). However, the performance of deep learning in predicting disease status is in an early stage (Wu 
et al., 2018).
An important recent advance in machine learning is the rapid development of deep learning algo-
rithms that can efficiently extract meaningful characteristics from complex high-dimensional datasets 
through a hierarchical stacked learning process. There are few studies like of Wu et al. (2018) and 
Telenti et al, (2018) where they applied the Deep Learning approach to predict disease status based on 
genomic data indicating. However, to predict disease status is still in its infancy.
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5. Machine Learning ang Polygenic Risk Score
Genetic risk prediction models are generally constructed by: (1) polygenic risk rating; or (2) Ma-
chine learning. The predictive performance of both types of models is evaluated by the receiver’s 
operational characteristic curves (ROC) where the sensitivity and specificity of the predictions are 
classified into several cut-off values (Ho et al., 2019).
The use of Machine Learning and PRS techniques will depend very much on the type of genetic 
disease being studied. For example, for psychiatric diseases the PRS is generated by PRSice Software 
(https://prsice.info/) (Choi et al., 2019; Euesden et al., 2019) and genome-wide association studies as a 
complement to polygenic risk prediction. Other techniques are used such as multivariate relevant vec-
tor regression (RVR) where RVR is a nucleus-based probabilistic pattern recognition method that uses 
Bayesian inference to obtain dispersed regression models and allows the extraction of patterns within a 
high-dimensional characteristic space (Ranlund et al., 2018) a multivariate automatic learning method.
A new heuristic based on automatic learning techniques (GraBLD) is proposed to increase per-
formance and improve prediction of PRSs (Paré et al., 2017). This study demonstrated the use of ML 
techniques and GWAS to improve the prediction of polygenic traits where it proposes to take advan-
tage of the large number of SNPs and the statistics available at the summary level of genome-wide 
association study to calibrate the weights of SNPs that contribute to the polygenic risk score based on 
pruning the linkage disequilibrium (LD) of the SNPs, prioritizing the most significant associations up 
to an empirically determined p-value threshold and pruning the remaining LD-based SNPs (Paré et 
al., 2017). 
Weighted analysis of the genetic correlation network (WGCNA) has been used repeatedly for the 
successful identification of epigenetic and transcriptomic networks which relate to a number of physi-
cal behavioral and disease traits. Morgan’s study (Levine et al., 2017) demonstrates a WGCNA-based 
method that can be applied to SNP data called weighted SNP correlation network analysis (WSCNA). 
In addition to taking into account the influence of LD this method also incorporates a semi-supervised 
ML approach that will facilitate the detection of modules that are specific to each trait where GWAS, 
PRS and heritability analysis have been extensively studied.
Despite recent improvements, the results of the polygenic risk score remain limited due to the ap-
proaches currently in use. In contrast, ML algorithms have increased predictive capabilities for the risk 
of complex diseases. This increase in predictive capabilities results from the ability of ML to handle 
multidimensional data (Ho et al., 2019).
5.1. Comparations between Machine Learning and Polygenic Risk Score
Polygenic risk scoring and machine learning are two main approaches to predicting disease risk. 
Despite recent improvements the polygenic risk score results remain limited due to the approaches cur-
rently used like the Pisanu’s study where said “the prediction accuracy shown by the PRS in the study 
is still in-sufficient to support the implementation of the model into the clinical practice” (Pisanu et 
al., 2019). In contrast, machine learning algorithms have increased predictive capabilities for the risk 
of complex diseases (Ho et al., 2019). However, there are other studies that indicate that PRS remains 
the best option for classifying cases of diseases such as schizophrenia (Griffiths et al., 2019; Doan et 
al., 2017; Cao et al., 2018).
There are studies such as that of Ho et al. (2019) which provides a general description of the poly-
genic risk score and machine learning in predicting the risk of complex diseases. Highlighting recent 
10
Nibeth Mena Mamani 
Machine Learning techniques and Polygenic Risk 
Score application to prediction genetic diseases
ADCAIJ: Advances in Distributed Computing 
and Artificial Intelligence Journal 
Regular Issue, Vol. 9 N. 1 (2020), 5-14
eISSN: 2255-2863 - https://adcaij.usal.es
Ediciones Universidad de Salamanca - cc by-nc-nd
developments in machine learning applications and how machine learning approaches can lead to 
better prediction of complex diseases.
 Figure 2 summarizes the strengths and weaknesses of both the polygenic risk score and the auto-
matic learning predictive models (Ho et al., 2019).
Figure 2: The strengths and weaknesses of polygenic risk scoring  
and machine learning model (Ho et al., 2019).
6. Discussion
Since genomic sequencing was achieved GWAS and PRS have become a powerful tool for predict-
ing the genetic predisposition of diseases. According to the reviewed articles using of PRS in peculiar 
diseases such as breast cancer, diabetes and obesity is very high (Shieh et al., 2017; Kuchenbaecker et 
al., 2017; Reisberg et al., 2017; Torkamani et al., 2019) but some articles identified that PRS is affected 
by environmental risk factors, heritability, diet, exercise, even sex and age. On the other hand, these 
factors are better handled by the ML tools but the limiting factor in it as already mentioned in other 
sections is the data for training, validation and tests.
Machine learning techniques are used after previous selection of the set of existing techniques 
based on the characteristics of variables and parameters in the data to be analyzed, for example if you 
have images as a data set you will have to use SVM. It would not be too much to have justifications and 
orientations of why to choose a particular technique. ML techniques have helped to solve a wide range 
of prediction problems but they are not widely used to construct polygenic risk scores for predicting 
complex traits (Paré et al., 2017).
A study has three methods selected for Parkinson’s diseases (Gao et al., 2018). These three tech-
niques will not have the same impact on schizophrenia diseases. PRS and ML are unique for each 
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type of disease. That means that once obtained they cannot be reused in other diseases. It is also very 
important to know the type of information what type of data you have as a sample and to know all 
the variables AND parameters so the interpretation of results is easy and significant. In addition to be 
able to select a group of techniques that complement and provide better prediction accuracy likewise 
a group of techniques should be used because it is necessary to make comparisons of the results of the 
experiment and evaluate the performance of each technique to see which one of them allows us to have 
a better precision of the risk of a disease. 
Results from studies by Paré et al. (2017) show that ML techniques together with large meta-anal-
ysis data from the entire genome and the large number of genetic variants reported in GWAS to train 
gradient powered regression tree models through genome division improve the prediction of polygenic 
traits (Paré et al., 2017) It means that they are in favor of ML techniques for disease prediction.
Deep learning as a proposal for disease prediction too, because in the studies reviewed they men-
tioned the number of hidden layers and the number of nodes in each hidden layer used for automatic 
encoders but no justifications and guidance were given on why to choose those specific numbers of 
hidden layers and those specific numbers of nodes in each hidden layer. This is probably one of the 
main reasons why deep learning has not been widely used in genomic research (Wu et al., 2018). 
The main limitation of the studies is related to the sample size that may be relatively small for the 
purposes of genetic studies (Ranlund et al., 2018; Telenti et al., 2018) where the number of genomic 
factors is much greater than the number of samples, which results in an excessive adjustment of the 
model and computational inefficiency (Wu et al., 2018) and it could be a strong reason why we don’t 
even trust Machine learning prediction methods to clinically make the corresponding decision mak-
ing. Applying machine learning or Deep learning techniques not only entails having great data for the 
training and testing of the proposed models but also requires super computations (https://hpcc.usc.
edu/) of high performance.
7. Conclusion
PRS is a statistical method to predict diseases with multiple genetic variations and ML tools are 
other computational techniques that also predict diseases with genetic variations. There are studies that 
show that ML can improve the prediction of a specific disease as there are also studies that indicate that 
traditional PRS is better than ML to predict. What will it depend on? it could depend a lot on the type 
of disease. The values  that GWAS provides or other genetic and external factors that are under study. It 
is evident that both go in parallel paths but aiming at the same objective: To predict more accurately the 
risk of contracting a genetic disease. Finally, for both approaches the research and experiments must 
be continued by the scientific community facing all the challenges that arise and take full advantage of 
the full potential of Machine Learning to achieve high precision in the predictions and thus be able to 
make clinical decisions about detection and / or early intervention of genetic diseases.
8. Future work
The ML techniques predicting, diagnose the disease, personalize the treatment and develop new 
medicines as report the Kristy et al. (2018) and Wu et al. (2018) articles. It is important to make 
full use of existing prediction techniques from traditional PRS, ML and data mining techniques if 
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intelligently bringing together all the techniques in the corresponding phases and with required data 
in terms of quality and quantity them could have a greater approximation to the high precision of 
predictions of polygenic diseases. Something very interesting is the following article by Ripke et al. 
(2019) which was recently published where it refers to a path based on the Polygenic Risk Score using 
prediction techniques and classification of Machine Learning (Ripke et al., 2019).
This literature review was conducted at a general level. It would be very interesting to have a study 
on ML algorithms used to predict a particular disease or to have an area of  focus, for example ML tech-
niques to predict diseases like oncology, neurological, schizophrenia, parkinson, alzheimer, prostate 
cancer, breast cancer, etc. Having the techniques used in different studies for the same disease, let’s say 
3 to 4 ML techniques we should look the benefits that ML techniques offer and how much precision 
they have in predicting the disease under study in addition to the comparison these techniques of ML 
and traditional PRSs have been defined in other studies with the help of GWAS of course under the 
same disease.
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